These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 16532541)

  • 1. New drug to treat rare leukemia and lymphoma.
    FDA Consum; 2006; 40(1):4-5. PubMed ID: 16532541
    [No Abstract]   [Full Text] [Related]  

  • 2. Nelarabine (Arranon) for T-cell acute lymphoblastic leukemia.
    Med Lett Drugs Ther; 2006 Feb; 48(1228):14-5. PubMed ID: 16467734
    [No Abstract]   [Full Text] [Related]  

  • 3. Nelarabine induced complete remission in an adult with refractory T-lineage acute lymphoblastic leukemia: A case report and review of the literature.
    Sigalas P; Tourvas AD; Moulakakis A; Pangalis G; Kontopidou F
    Leuk Res; 2009 Jul; 33(7):e61-3. PubMed ID: 19157550
    [No Abstract]   [Full Text] [Related]  

  • 4. FDA drug approval summary: nelarabine (Arranon) for the treatment of T-cell lymphoblastic leukemia/lymphoma.
    Cohen MH; Johnson JR; Justice R; Pazdur R
    Oncologist; 2008 Jun; 13(6):709-14. PubMed ID: 18586926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nelarabine.
    Gandhi V; Keating MJ; Bate G; Kirkpatrick P
    Nat Rev Drug Discov; 2006 Jan; 5(1):17-8. PubMed ID: 16485343
    [No Abstract]   [Full Text] [Related]  

  • 6. Approval summary: nelarabine for the treatment of T-cell lymphoblastic leukemia/lymphoma.
    Cohen MH; Johnson JR; Massie T; Sridhara R; McGuinn WD; Abraham S; Booth BP; Goheer MA; Morse D; Chen XH; Chidambaram N; Kenna L; Gobburu JV; Justice R; Pazdur R
    Clin Cancer Res; 2006 Sep; 12(18):5329-35. PubMed ID: 17000665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nelarabine use in leukemias.
    Kisor DF
    Drugs Today (Barc); 2006 Jul; 42(7):455-65. PubMed ID: 16894400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical trials referral resource. Clinical trials using compound 506U78.
    Ho PT; Cheson BD; Phillips PH
    Oncology (Williston Park); 1996 Dec; 10(12):1831-2. PubMed ID: 9063861
    [No Abstract]   [Full Text] [Related]  

  • 9. Quest for effective agents to combat T-cell acute lymphoblastic leukemia.
    Pui CH
    Eur J Cancer; 2005 Jun; 41(9):1243-5. PubMed ID: 15939259
    [No Abstract]   [Full Text] [Related]  

  • 10. Nelarabine: a novel purine antimetabolite antineoplastic agent.
    Buie LW; Epstein SS; Lindley CM
    Clin Ther; 2007 Sep; 29(9):1887-99. PubMed ID: 18035189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nelarabine: efficacy in the treatment of clinical malignancies.
    Roecker AM; Allison JC; Kisor DF
    Future Oncol; 2006 Aug; 2(4):441-8. PubMed ID: 16922610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acute lymphoblastic leukemia, type T: therapeutic results].
    Melero C; López J; García-Muñoz F; Auray C; García MJ; Gil C; Valverde F; Aracil J; Bernacer M; Contra T
    An Esp Pediatr; 1988 Oct; 29 Suppl 34():62-6. PubMed ID: 3214040
    [No Abstract]   [Full Text] [Related]  

  • 13. Blocking NF-kappaB as a potential strategy to treat adult T-cell leukemia/lymphoma.
    Horie R; Watanabe T; Umezawa K
    Drug News Perspect; 2006 May; 19(4):201-9. PubMed ID: 16823495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is zidovudine and interferon-alfa the gold standard for adult T-cell leukemia-lymphoma?
    Ishitsuka K; Fukushima T; Tsukasaki K; Tobinai K
    J Clin Oncol; 2010 Dec; 28(36):e765; author reply e766. PubMed ID: 20921454
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful use of etretinate for long-term management of a patient with cutaneous-type adult T-cell leukaemia/lymphoma.
    Inozume T; Matsue H; Furuhashi M; Nakamura Y; Mitsui H; Ando N; Mitzutani M; Miyahara A; Kawamura T; Shibagaki N; Tsukamoto K; Shimada S
    Br J Dermatol; 2005 Dec; 153(6):1239-41. PubMed ID: 16307674
    [No Abstract]   [Full Text] [Related]  

  • 16. Nelarabine activity in acute biphenotypic leukemia.
    Alvarado Y; Welch MA; Swords R; Bruzzi J; Schlette E; Giles FJ
    Leuk Res; 2007 Nov; 31(11):1600-3. PubMed ID: 17512588
    [No Abstract]   [Full Text] [Related]  

  • 17. A tale of two drugs.
    Nat Rev Drug Discov; 2006 Oct; 5(10):803. PubMed ID: 17078168
    [No Abstract]   [Full Text] [Related]  

  • 18. Progressive ascending paraparesia in an acute lymphoblastic leukemia patient: masked but not fallacious.
    Ozcakar L; Karadag O; Isik M; Elkiran ET; Dikbas O; Altundag K
    J Exp Clin Cancer Res; 2004 Jun; 23(2):365-6. PubMed ID: 15354425
    [No Abstract]   [Full Text] [Related]  

  • 19. Nelarabine: new drug. T-lymphoblastic leukaemia/lymphoma: more evaluation needed.
    Prescrire Int; 2009 Feb; 18(99):3-5. PubMed ID: 19382393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Provocative gene therapy strategy for the treatment of hepatocellular carcinoma.
    Askari F; Wilson J
    Hepatology; 1992 Jul; 16(1):273-4. PubMed ID: 1319955
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.